A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects
Status:
Completed
Trial end date:
2016-09-20
Target enrollment:
Participant gender:
Summary
This is a phase 1 open label single centre study of AZD9496 administered orally in healthy
volunteers. The study design involves single administration of different forms, formulations
and doses of AZD9496. The study is designed to investigate these different AZD9496 variants.
The study will evaluate the pharmacokinetic profiles and the safety and tolerability of the
different forms, formulations and doses of AZD9496
This is a fixed sequence study with 5-sequential treatment periods in healthy volunteers.
Each volunteer will receive 5 single doses of AZD9496 in different forms, formulations and
doses.